Personal information

Emails & domains

Verified email domains

Websites & social links

Rokita Lab

Other IDs

Scopus Author ID: 37088463900
Scopus Author ID: 55407286400
Loop profile: 919593

Activities

Collapse all

Employment (4)

Children's National Hospital: Washington, US

2024-10-28 to present | Director, Brain Tumor Institute Bioinformatics Core (Center for Cancer and Immunology Research)
Employment
Source: Self-asserted source
Jo Lynne Rokita (Harenza)

The Children's Hospital of Philadelphia: Philadelphia, PA, US

2015-08 to 2024-10-18 | Supervisory Bioinformatics Scientist (Center for Data-Driven Discovery in Biomedicine)
Employment
Source: Self-asserted source
Jo Lynne Rokita (Harenza)

National Cancer Institute: Bethesda, MD, US

2014-12 to 2015-07-31 | Research Collaborator (Oncogenomics Group)
Employment
Source: Self-asserted source
Jo Lynne Rokita (Harenza)

National Institute of Standards and Technology: Gaithersburg, MD, US

2013-09 to 2015-07 | Research Biologist (Applied Genetics Group)
Employment
Source: Self-asserted source
Jo Lynne Rokita (Harenza)

Education and qualifications (3)

Virginia Commonwealth University: Richmond, VA, US

2008 to 2013 | Ph.D. (Pharmacology and Toxicology)
Education
Source: Self-asserted source
Jo Lynne Rokita (Harenza)

Arcadia University: Glenside, PA, US

2006 to 2008 | M.S. (Forensic Science)
Education
Source: Self-asserted source
Jo Lynne Rokita (Harenza)

Pennsylvania State University University Park: University Park, PA, US

2001 to 2005 | B.S. (Science, Life Science Option)
Education
Source: Self-asserted source
Jo Lynne Rokita (Harenza)

Funding (2)

Identification and characterization of genetic risk factors in pediatric brain tumors

2023-12-01 to 2025-11-30 | Grant
National Cancer Institute (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.13815839
GRANT_NUMBER: R03CA287169
Source: Self-asserted source
Jo Lynne Rokita (Harenza) via DimensionsWizard

Discovery of neoepitope immunotherapeutic targets in diffuse pediatric high-grade gliomas

2023-09-20 to 2025-09-19 | Grant
Office of the Director (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.13615416
GRANT_NUMBER: R03OD036498
Source: Self-asserted source
Jo Lynne Rokita (Harenza) via DimensionsWizard

Peer review (11 reviews for 5 publications/grants)

Review activity for Nature cancer. (1)
Review activity for Nature communications (2)
Review activity for Nature genetics. (1)
Review activity for Nature medicine. (6)
Review activity for Signal transduction and targeted therapy. (1)
How many people are using ORCID?